Introduction

Prostate health remains one of the most neglected areas of men's healthcare in India. Despite being one of the most commonly diagnosed cancers among men globally, prostate cancer continues to be diagnosed late in India, often because men either do not know the warning signs or choose to ignore them due to social hesitation. September is recognised as Prostate Cancer Awareness Month across the world, and it serves as a timely reminder that prostate health cannot be treated as a secondary concern.

According to data from GLOBOCAN and the Indian Council of Medical Research (ICMR), prostate cancer incidence among Indian men has been gradually rising, particularly in urban centres such as Delhi, Mumbai, Bengaluru, and Pune. The shift in lifestyle patterns, ageing population, and increased diagnostic reach have all contributed to greater detection. However, awareness at the community level still lags significantly behind the clinical reality.

Medicircle, as a trusted healthcare communication platform connecting patients, doctors, hospitals, and health brands across India, considers prostate health awareness to be central to responsible public health communication. This article brings together evidence-based information on the prostate gland, cancer risk, symptoms, diagnostic tests, and prevention strategies, with a focus on relevance for Indian men across age groups and geographies.

Understanding the Prostate Gland and Why Its Health Matters

The prostate is a small, walnut-sized gland located just below the bladder and in front of the rectum in the male body. Its primary biological function is to produce a fluid that nourishes and transports sperm during ejaculation, making it an essential component of the male reproductive system. Despite its modest size, the prostate has an outsized influence on urinary function, sexual health, and hormonal balance.

The gland surrounds the urethra, the tube through which urine exits the body. This anatomical positioning explains why prostate disorders, whether cancerous or benign, so frequently manifest as urinary symptoms. As men age, the prostate naturally grows larger, and this growth can compress the urethra and interfere with normal urination.

While prostate cancer is the most widely discussed condition, there are other important prostate health conditions that Indian men should be aware of:

• Benign Prostatic Hyperplasia (BPH): A non-cancerous enlargement of the prostate that becomes increasingly common in men over 50. BPH does not cause cancer but can significantly impair quality of life through urinary symptoms.
• Prostatitis: Inflammation of the prostate, which can be bacterial or non-bacterial in origin. It often causes pelvic pain, difficulty urinating, and discomfort during ejaculation.
• Prostate Cancer: The malignant growth of prostate cells that, when detected early, has a very high survival rate but can become life-threatening if it spreads to surrounding tissue or distant organs.

Understanding that not all prostate problems indicate cancer is important. It removes unnecessary fear while still emphasising the need for timely medical evaluation.

Primary Causes and Risk Factors for Prostate Cancer in Indian Men

The exact cause of prostate cancer at a cellular level involves changes in the DNA of prostate cells that cause them to grow uncontrollably. While no single cause has been definitively isolated, researchers and clinicians have identified a clear set of risk factors that increase a man's likelihood of developing this condition.

Age is the most significant non-modifiable risk factor. The vast majority of prostate cancer cases occur in men over the age of 50, with risk rising sharply after 60. This demographic shift is increasingly relevant in India, where a growing proportion of the population is entering older age groups.

Genetic and family history plays a considerable role. Men with a first-degree relative, such as a father or brother, who has been diagnosed with prostate cancer carry a meaningfully higher risk. Inherited genetic mutations, particularly those involving the BRCA1 and BRCA2 genes, are also linked to elevated risk. These genetic patterns are not unique to Western populations; they are being increasingly identified in Indian family cohorts as well.

Dietary patterns common in urban India, including high intake of red meat, processed foods, refined carbohydrates, and dairy, have been associated in multiple studies with increased prostate cancer risk. Conversely, diets rich in fruits, vegetables, legumes, and antioxidant-dense foods appear to offer some protective effect. The traditional Indian vegetarian diet, when followed with nutritional balance, may offer inherent advantages in this regard.

Physical inactivity and obesity are emerging risk factors in the Indian urban context. Sedentary work environments, reduced physical activity, and increasing rates of abdominal obesity among working-age Indian men are contributing to a broader hormonal and metabolic environment that may heighten cancer risk.

Tobacco use and alcohol consumption, while studied with mixed outcomes in relation to prostate cancer specifically, are known to increase overall oncological burden and compromise the body's immune defences.

Recognising the Symptoms of Prostate Disease

One of the most challenging aspects of prostate cancer is that it often develops without noticeable symptoms in its early stages. This is particularly true for localised cancer confined to the prostate gland. Many men feel entirely normal for years while the disease progresses silently, which makes routine screening critically important.

When symptoms do emerge, they are frequently related to urinary function, given the prostate's anatomical proximity to the urethra. Common signs that warrant immediate medical consultation include:

• A persistent need to urinate frequently, especially at night (nocturia)
• Difficulty starting urination or maintaining a steady stream
• A feeling of incomplete bladder emptying after urinating
• A weak or interrupted urine flow
• Burning or pain during urination
• Blood in urine (haematuria) or blood in semen (haematospermia)
• Dull, persistent pain in the lower back, pelvis, or hips
• Difficulty achieving or maintaining an erection

It is important to note that these symptoms are not exclusive to prostate cancer. BPH, prostatitis, urinary tract infections, and other conditions can produce similar signs. However, the appropriate response to any of these symptoms is medical evaluation, not self-diagnosis or delay.

In advanced prostate cancer, where the disease has spread beyond the gland, symptoms may include significant fatigue, unexplained weight loss, bone pain particularly in the spine and pelvis, and weakness in the lower limbs. These presentations indicate that the cancer has become systemic and requires urgent specialist care.

Diagnosis and Medical Evaluation

Early and accurate diagnosis is what separates a manageable condition from a crisis. Prostate cancer screening and diagnosis in India is evolving, with growing availability of sophisticated testing in tier 1 cities and gradually improving access in tier 2 urban centres.

The Prostate-Specific Antigen or PSA test is the most widely used initial screening tool. PSA is a protein secreted by prostate cells, and its levels in the bloodstream are measured through a simple blood draw. Elevated PSA values may indicate cancer, but they can also reflect BPH, prostatitis, or recent physical activity affecting the prostate. A high PSA result is therefore a signal for further investigation, not a definitive diagnosis in itself.

Indian urologists and oncologists generally recommend discussing PSA screening with a doctor from age 50 for average-risk men, and from age 40 to 45 for men with a family history of prostate cancer or other significant risk factors.

The Digital Rectal Examination, or DRE, is a physical examination in which a physician uses a gloved finger inserted into the rectum to feel the size, shape, and surface texture of the prostate. An abnormal feel, such as hardness, irregularity, or asymmetry, may indicate a problem worth investigating further. Many men in India are hesitant to undergo this examination due to discomfort or embarrassment, but it remains a clinically valuable tool, particularly when used alongside PSA testing.

If initial tests suggest an abnormality, a multi-parametric MRI of the prostate offers detailed imaging to identify suspicious areas. This non-invasive imaging step has significantly improved prostate cancer detection accuracy in recent years and is increasingly available at leading cancer centres and radiology facilities across India.

A prostate biopsy, in which small tissue samples are taken from the gland and examined under a microscope, remains the definitive method for confirming cancer. The Gleason score, assigned based on biopsy analysis, helps physicians understand the aggressiveness of the tumour and guides treatment planning.

Treatment Options and Management Strategies

Treatment decisions for prostate cancer are highly individualised and depend on several factors, including the stage of cancer, the Gleason score, the patient's age, overall health, and personal preferences regarding quality of life.

Active surveillance is a carefully monitored approach recommended for men with low-risk, slow-growing prostate cancer. Rather than immediate intervention, regular PSA monitoring, imaging, and repeat biopsies track the cancer over time. Treatment begins only if the cancer shows signs of progression. This approach reduces unnecessary treatment burden and side effects.

Radical prostatectomy involves the surgical removal of the prostate gland. Modern robotic-assisted surgical techniques, now available at major hospitals in India, have significantly reduced recovery time and surgical complications compared to traditional open procedures.

Radiation therapy, delivered either externally (external beam radiation) or through internally implanted radioactive seeds (brachytherapy), targets and destroys cancer cells. It is an effective option for both localised and locally advanced prostate cancer.

Hormone therapy, also called androgen deprivation therapy, reduces the levels of male hormones such as testosterone that fuel prostate cancer growth. It is commonly used in advanced cases or in combination with radiation therapy.

Chemotherapy and immunotherapy are typically reserved for aggressive or metastatic prostate cancer and are administered under the supervision of a medical oncologist.

Many men in India seek complementary support through Ayurveda, yoga, and dietary modifications during and after cancer treatment. While these approaches can support overall wellbeing and recovery, they should be pursued as complements to, and never replacements for, evidence-based conventional treatment. Patients should always disclose all supplementary treatments to their oncologists.

Prevention and Proactive Health Measures

While it is not possible to guarantee complete prevention of prostate cancer, a proactive lifestyle significantly reduces risk and supports overall prostate health. Indian men, particularly those in urban areas experiencing lifestyle transitions, stand to benefit greatly from prevention-focused habits.

A diet modelled on traditional Indian food values, rich in vegetables such as tomatoes, cruciferous vegetables like cauliflower and broccoli, legumes, and whole grains, provides antioxidants and phytochemicals associated with lower cancer risk. Reducing consumption of processed meats, high-fat dairy, and packaged foods is equally important.

Regular physical activity, including brisk walking, swimming, cycling, or yoga, supports healthy hormone levels, reduces obesity risk, and builds overall metabolic resilience. Indian public health initiatives under the National Health Mission and programmes linked to Ayushman Bharat increasingly emphasise preventive health and lifestyle medicine, making it easier for men to access wellness support.

Avoiding tobacco in any form and limiting alcohol consumption reduce the compounded cancer burden across multiple organ systems. These remain foundational health recommendations endorsed by the World Health Organization, ICMR, and the Indian Ministry of Health and Family Welfare.

Regular medical check-ups, especially for men over 40 with any recognised risk factors, are perhaps the single most impactful preventive measure. Prostate health is not a one-time conversation; it is an ongoing dialogue between a man and his physician that evolves with age and health status.

Frequently Asked Questions

Q1: At what age should Indian men start prostate cancer screening?

Men at average risk should discuss prostate screening with their doctor from age 50. Men with a family history of prostate cancer or other high-risk factors should begin the conversation at age 40 to 45. A PSA blood test is the most common starting point for screening.

Q2: What is the PSA test and how does it help detect prostate problems?

PSA stands for Prostate-Specific Antigen, a protein produced by the prostate gland. A PSA blood test measures its concentration in the blood. Elevated PSA levels may indicate prostate cancer, benign prostatic hyperplasia, or prostate infection. It is used as an initial screening tool, and further tests such as MRI or biopsy confirm the actual diagnosis.

Q3: Is prostate cancer common in India?

Though historically less prevalent than in Western countries, prostate cancer incidence is rising in India. The age-standardised incidence rate in India is approximately 5 to 9 per 100,000 men, with urban populations showing higher rates due to lifestyle changes, greater life expectancy, and improved diagnostic access.

Q4: Can prostate cancer be prevented through diet and lifestyle changes?

While no diet or lifestyle choice guarantees complete prevention, evidence suggests that a plant-rich diet, regular physical activity, avoiding smoking and excessive alcohol, and maintaining a healthy body weight significantly reduce the risk of developing prostate cancer and related conditions.

Q5: What is the difference between benign prostatic hyperplasia and prostate cancer?

Benign prostatic hyperplasia, or BPH, refers to a non-cancerous enlargement of the prostate gland that commonly occurs as men age. While BPH can cause urinary symptoms similar to those of prostate cancer, it does not increase the direct risk of developing cancer. Only a doctor's evaluation, including PSA testing and imaging, can distinguish between the two conditions.

Resources

1. Indian Council of Medical Research (ICMR): National Cancer Registry Programme data and cancer awareness publications for India
2. World Health Organization (WHO): International Agency for Research on Cancer (IARC) GLOBOCAN global cancer statistics and prostate cancer burden estimates
3. Ministry of Health and Family Welfare, Government of India: National Health Mission guidelines on non-communicable disease prevention and men's health
4. PubMed/National Library of Medicine (pubmed.ncbi.nlm.nih.gov): Peer-reviewed research on prostate cancer epidemiology, screening, and treatment
5. National Cancer Grid India (NCG): Evidence-based guidelines for prostate cancer management in the Indian clinical setting

Interlinking Keywords

prostate cancer symptoms in men, PSA test India, men's health screening India, benign prostatic hyperplasia treatment, prostate cancer awareness month, prostate cancer risk factors India, urinary problems in older men, cancer prevention diet India, ICMR cancer statistics, Ayushman Bharat cancer care

Last medically reviewed by:

Medicircle Medical Review Board on 29 July 2026

Medical Disclaimer:

This article is intended for general awareness and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. The information presented here is based on publicly available evidence-based sources and should not be used as a substitute for professional medical consultation. Men experiencing any of the symptoms described in this article should consult a qualified urologist or oncologist for a proper clinical evaluation. Medicircle does not endorse any specific treatment, diagnostic product, or healthcare provider mentioned in this article.